( NASDAQ-NMS:ENDP )

News from endo pharmaceuticals A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Feb 16, 2016, 07:00 ET Endo to Announce Fourth Quarter 2015 Financial Results on February 29, 2016

 Endo International plc (NASDAQ: ENDP) (TSX: ENL) will announce its fourth quarter 2015 financial results before the open of the U.S. financial...


Oct 26, 2015, 06:00 ET U.S. FDA Approves BELBUCA™ (buprenorphine) Buccal Film for Chronic Pain Management

New treatment option combines proven efficacy and established safety profile of buprenorphine with a novel delivery system that adds convenience...


May 18, 2015, 06:30 ET Endo to Acquire Par Pharmaceutical, Strategically Expanding Generics Business to a Top 5 Industry Leader

- Transaction valued at $8.05 billion is transformative for Endo, creating a powerful platform for future growth and further strategic...


Dec 23, 2014, 15:42 ET Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain

 Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), and BioDelivery Sciences International, Inc....


Sep 08, 2014, 12:00 ET Endo to Present at Morgan Stanley Global Healthcare Conference 2014

 Endo International plc (NASDAQ: ENDP) (TSX: ENL) announced today that Rajiv De Silva, President and CEO, will present a corporate overview at...


Jul 07, 2014, 07:00 ET Endo and BioDelivery Sciences announce positive top-line results from the Phase III clinical trial of BEMA® buprenorphine in opioid-experienced patients with chronic pain

 Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), and BioDelivery Sciences...


Apr 09, 2014, 07:00 ET Louis Van Amstel, Former Dancing with the Stars Professional, Joins "Making Your Move" Campaign to Raise Awareness of Osteoarthritis

 Emmy-nominated choreographer, nine-time Dancing with the Stars professional and creator of LaBlast dance fitness program Louis...


Mar 06, 2014, 07:00 ET U.S. FDA Approves AVEED™ (Testosterone Undecanoate) Injectable Testosterone Replacement Therapy For Men Living With Hypogonadism, Or Low-T

Endo International plc (NASDAQ: ENDP) (TSX: ENL) announced today that its operating company Endo Pharmaceuticals Inc. received U.S. Food and...


Feb 21, 2014, 12:49 ET Endo Announces Resolution of Government Investigation

Endo Pharmaceuticals, a subsidiary of Endo Health Solutions Inc. (Nasdaq: ENDP), announced today that it has reached a resolution of criminal and...


Feb 20, 2014, 14:00 ET Endo to Announce Fourth Quarter 2013 Financial Results on February 28, 2014

 Endo Health Solutions (Nasdaq: ENDP) will announce its fourth quarter 2013 financial results before the open of the U.S. financial markets on...


Jan 23, 2014, 16:30 ET Endo and BioDelivery Sciences Announce Positive Top-Line Results from the Phase III Clinical Trial of BEMA Buprenorphine in Opioid Naive Patients with Chronic Pain

 Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. (Nasdaq: ENDP), and BioDelivery Sciences International, Inc. (Nasdaq:...


Sep 05, 2013, 08:01 ET FDA Accepts Endo's Complete Response Submission to New Drug Application for AVEED™ (Testosterone Undecanoate) Injection

 Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. (Nasdaq: ENDP) announced today that the U.S. Food and Drug...


Sep 04, 2013, 06:00 ET Endo and BioDelivery Sciences Provide Update on BEMA Buprenorphine Phase III Development Program

 Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. (Nasdaq: ENDP), and BioDelivery Sciences International, Inc. (Nasdaq:...


May 30, 2013, 16:17 ET Endo Pharmaceuticals Provides Regulatory Update On AVEED™ (Testosterone Undecanoate) Injection

 Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. (Nasdaq: ENDP) announced today that the U.S. Food and Drug...


Oct 04, 2012, 07:00 ET Endo Health Solutions Will Detail Long-Term Strategy At 2012 Investor Day

- Highlights long-term growth drivers and investment attributes of the company - Endo updates 2012 performance, reaffirms full year...


Sep 26, 2012, 16:10 ET Endo Health Solutions Announces Receipt of Paragraph IV Certifications for OPANA® ER

 Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions (Nasdaq: ENDP), announced today that the company has received Paragraph IV...


Sep 06, 2012, 08:30 ET Endo Pharmaceuticals Announces Reformulated Version of OPANA® ER with INTAC® Technology Designed to be Crush-Resistant Accounts for more than 90 Percent of OPANA ER Total Prescription Volume

Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. (Nasdaq: ENDP), today announced that, according to the latest IMS data...


May 23, 2012, 14:00 ET Endo Health Solutions Inc. Announced as New Name for Endo Pharmaceuticals Holdings Inc.

Shareholders of Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP) voted today at its annual shareholders meeting to approve changing the company's...


May 04, 2012, 10:00 ET Endo to Present at Bank of America Merrill Lynch 2012 Health Care Conference

Endo (Nasdaq: ENDP) today announced that Alan Levin, executive vice president and chief financial officer, will present a corporate overview at the...


Apr 17, 2012, 09:00 ET Endo Pharmaceuticals to Announce First Quarter 2012 Financial Results on May 1, 2012

Endo Pharmaceuticals Holdings (Nasdaq: ENDP) will announce its first quarter 2012 financial results on May 1, 2012 and will host a conference call...


Mar 29, 2012, 13:30 ET Endo Announces Departure of American Medical Systems President

Endo (Nasdaq: ENDP) announced today that American Medical Systems' (AMS) Group President, Tony Bihl, will step down as head of the Endo devices...


Mar 13, 2012, 08:30 ET Endo Files Amended Citizen Petition Seeking Public FDA Resolution of Several Safety and Efficacy Issues Prior to Approval of a Generic Formulation of LIDODERM®

 Endo Pharmaceuticals (Nasdaq: ENDP) announced today that it has filed an amendment to its Citizen Petition (CP) with the U.S. Food and Drug...


Mar 01, 2012, 08:30 ET Endo Pharmaceuticals Announces Proposal to Change Name of Parent Company and Rebrands Enterprise: Revealing an Innovative Corporate Structure Dedicated to Redefining Healthcare Value

Endo (Nasdaq: ENDP), a diversified healthcare solutions company, today announced the aggregation of its operating companies as part of an...


Feb 24, 2012, 07:00 ET Endo Pharmaceuticals Reports Strong Fourth Quarter Financial Results; Provides 2012 Financial Guidance

Endo Pharmaceuticals (Nasdaq: ENDP) today reported financial results for the fourth quarter of 2011. Total revenues during the fourth quarter of...


Feb 22, 2012, 16:30 ET Endo Pharmaceuticals to Present at Cowen & Co. 32nd Annual Health Care Conference

 Endo Pharmaceuticals Holdings (Nasdaq: ENDP) today announced that Julie McHugh, chief operating officer, will present a corporate...